Cargando…

Spectrum of sublytic astrocytopathy in neuromyelitis optica

Neuromyelitis optica is an autoimmune inflammatory disorder targeting aquaporin-4 water channels in CNS astrocytes. Histopathological descriptions of astrocytic lesions reported in neuromyelitis optica so far have emphasized a characteristic loss of aquaporin-4, with deposition of IgG and complement...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yong, Lennon, Vanda A, Parisi, Joseph E, Popescu, Bogdan, Vasquez, Christina, Pittock, Sean J, Howe, Charles L, Lucchinetti, Claudia F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128820/
https://www.ncbi.nlm.nih.gov/pubmed/34718426
http://dx.doi.org/10.1093/brain/awab394
_version_ 1784712624597893120
author Guo, Yong
Lennon, Vanda A
Parisi, Joseph E
Popescu, Bogdan
Vasquez, Christina
Pittock, Sean J
Howe, Charles L
Lucchinetti, Claudia F
author_facet Guo, Yong
Lennon, Vanda A
Parisi, Joseph E
Popescu, Bogdan
Vasquez, Christina
Pittock, Sean J
Howe, Charles L
Lucchinetti, Claudia F
author_sort Guo, Yong
collection PubMed
description Neuromyelitis optica is an autoimmune inflammatory disorder targeting aquaporin-4 water channels in CNS astrocytes. Histopathological descriptions of astrocytic lesions reported in neuromyelitis optica so far have emphasized a characteristic loss of aquaporin-4, with deposition of IgG and complement and lysis of astrocytes, but sublytic reactions have been underappreciated. We performed a multi-modality study of 23 neuromyelitis optica autopsy cases (clinically and/or pathologically confirmed; 337 tissue blocks). By evaluating astrocytic morphology, immunohistochemistry and AQP4 RNA transcripts, and their associations with demyelinating activity, we documented a spectrum of astrocytopathy in addition to complement deposition, microglial reaction, granulocyte infiltration and regenerating activity. Within advanced demyelinating lesions, and in periplaque areas, there was remarkable hypertrophic astrogliosis, more subtle than astrocytic lysis. A degenerative component was suggested by ‘dystrophic’ morphology, cytoplasmic vacuolation, Rosenthal fibres and associated stress protein markers. The abundance of AQP4 mRNA transcripts in sublytic reactive astrocytes devoid of aquaporin-4 protein supported in vivo restoration following IgG-induced aquaporin-4 endocytosis/degradation. Astrocytic alterations extending beyond demyelinating lesions speak to astrocytopathy being an early and primary event in the evolving neuromyelitis optica lesion. Focal astrocytopathy observed without aquaporin-4 loss or lytic complement component deposition verifies that astrocytic reactions in neuromyelitis optica are not solely dependent on IgG-mediated aquaporin-4 loss or lysis by complement or by IgG-dependent leucocyte mediators. We conclude that neuromyelitis optica reflects a global astrocytopathy, initiated by binding of IgG to aquaporin-4 and not simply definable by demyelination and astrocytic lysis. The spectrum of astrocytic morphological changes in neuromyelitis optica attests to the complexity of factors influencing the range of astrocytic physiological responses to a targeted attack by aquaporin-4-specific IgG. Sublytic astrocytic reactions are no doubt an important determinant of the lesion’s evolution and potential for repair. Pharmacological manipulation of the astrocytic stress response may offer new avenues for therapeutic intervention.
format Online
Article
Text
id pubmed-9128820
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-91288202022-05-25 Spectrum of sublytic astrocytopathy in neuromyelitis optica Guo, Yong Lennon, Vanda A Parisi, Joseph E Popescu, Bogdan Vasquez, Christina Pittock, Sean J Howe, Charles L Lucchinetti, Claudia F Brain Original Article Neuromyelitis optica is an autoimmune inflammatory disorder targeting aquaporin-4 water channels in CNS astrocytes. Histopathological descriptions of astrocytic lesions reported in neuromyelitis optica so far have emphasized a characteristic loss of aquaporin-4, with deposition of IgG and complement and lysis of astrocytes, but sublytic reactions have been underappreciated. We performed a multi-modality study of 23 neuromyelitis optica autopsy cases (clinically and/or pathologically confirmed; 337 tissue blocks). By evaluating astrocytic morphology, immunohistochemistry and AQP4 RNA transcripts, and their associations with demyelinating activity, we documented a spectrum of astrocytopathy in addition to complement deposition, microglial reaction, granulocyte infiltration and regenerating activity. Within advanced demyelinating lesions, and in periplaque areas, there was remarkable hypertrophic astrogliosis, more subtle than astrocytic lysis. A degenerative component was suggested by ‘dystrophic’ morphology, cytoplasmic vacuolation, Rosenthal fibres and associated stress protein markers. The abundance of AQP4 mRNA transcripts in sublytic reactive astrocytes devoid of aquaporin-4 protein supported in vivo restoration following IgG-induced aquaporin-4 endocytosis/degradation. Astrocytic alterations extending beyond demyelinating lesions speak to astrocytopathy being an early and primary event in the evolving neuromyelitis optica lesion. Focal astrocytopathy observed without aquaporin-4 loss or lytic complement component deposition verifies that astrocytic reactions in neuromyelitis optica are not solely dependent on IgG-mediated aquaporin-4 loss or lysis by complement or by IgG-dependent leucocyte mediators. We conclude that neuromyelitis optica reflects a global astrocytopathy, initiated by binding of IgG to aquaporin-4 and not simply definable by demyelination and astrocytic lysis. The spectrum of astrocytic morphological changes in neuromyelitis optica attests to the complexity of factors influencing the range of astrocytic physiological responses to a targeted attack by aquaporin-4-specific IgG. Sublytic astrocytic reactions are no doubt an important determinant of the lesion’s evolution and potential for repair. Pharmacological manipulation of the astrocytic stress response may offer new avenues for therapeutic intervention. Oxford University Press 2021-10-30 /pmc/articles/PMC9128820/ /pubmed/34718426 http://dx.doi.org/10.1093/brain/awab394 Text en © The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Article
Guo, Yong
Lennon, Vanda A
Parisi, Joseph E
Popescu, Bogdan
Vasquez, Christina
Pittock, Sean J
Howe, Charles L
Lucchinetti, Claudia F
Spectrum of sublytic astrocytopathy in neuromyelitis optica
title Spectrum of sublytic astrocytopathy in neuromyelitis optica
title_full Spectrum of sublytic astrocytopathy in neuromyelitis optica
title_fullStr Spectrum of sublytic astrocytopathy in neuromyelitis optica
title_full_unstemmed Spectrum of sublytic astrocytopathy in neuromyelitis optica
title_short Spectrum of sublytic astrocytopathy in neuromyelitis optica
title_sort spectrum of sublytic astrocytopathy in neuromyelitis optica
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128820/
https://www.ncbi.nlm.nih.gov/pubmed/34718426
http://dx.doi.org/10.1093/brain/awab394
work_keys_str_mv AT guoyong spectrumofsublyticastrocytopathyinneuromyelitisoptica
AT lennonvandaa spectrumofsublyticastrocytopathyinneuromyelitisoptica
AT parisijosephe spectrumofsublyticastrocytopathyinneuromyelitisoptica
AT popescubogdan spectrumofsublyticastrocytopathyinneuromyelitisoptica
AT vasquezchristina spectrumofsublyticastrocytopathyinneuromyelitisoptica
AT pittockseanj spectrumofsublyticastrocytopathyinneuromyelitisoptica
AT howecharlesl spectrumofsublyticastrocytopathyinneuromyelitisoptica
AT lucchinetticlaudiaf spectrumofsublyticastrocytopathyinneuromyelitisoptica